K161316

Substantially Equivalent

George King Coumadin Plasma

Applicant: George King Bio-Medical, Inc.
Product code: GGN
Advisory panel: Hematology
Date received: 2016-05-11
Decision date: 2017-02-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Overland Park, KS, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.